The firm's shares rose to $61.66 in afternoon trading on news that TPG and Blackstone had offered to take the firm private.

According to the FDA, the tubes are not being produced in conformity with good manufacturing practice and have led to false positive lead test results.

Last week, readers were most interested in a story about an MOU between Gene Solutions and NEWCL to establish a lab in Taiwan.

Following an executive reset, the Tokyo firm hopes to grow its molecular and immunochemical testing businesses.

During a fireside chat at the RBC Healthcare Conference, Bio-Rad's CFO Roop Lakkaraju confirmed the firm's prior guide for 130 basis points of net tariff impact, which Connor McNamera, RBC's moderator ...

The DOJ alleged Agendia submitted false claims to Medicare, Medicaid, and other government payors for its MammaPrint breast cancer test.

The firm presented data at AACR that showed the test had high accuracy when distinguishing ovarian cancer at early stages.

An unnamed party has made a bid to acquire Akoya at a price of $1.40 per share, which Akoya said could prove a superior proposal to its planned merger with Quanterix.

The French firm said that its CaloPix slide image viewing and management software is cleared for use with a pair of scanners from Hamamatsu and Leica.